CDRH Promotes Bayesian Tool To Speed Approvals; Statistical Rigor Required
This article was originally published in The Gray Sheet
Executive Summary
FDA is encouraging medical device firms to consider using Bayesian estimation in clinical trials to streamline regulatory timeframes